Miriam E. Tucker

Possible complications include adrenal insufficiency, hypogonadism, hyperprolactinemia, hospitalization, and mortality.

A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility improvement with GLP-1 use.

A follow-up of the T4DM trial in men with prediabetes or recent-onset type 2 diabetes show no further glycemic improvement after 2 years without ongoing lifestyle modification.

While most experts agree that PCOS needed a new name, some participants at ENDO 2026 questioned both the new PMOS terminology and the process used to develop it.

June 26, 2026 CHICAGO — Not everyone is embracing the new term “polyendocrine metabolic ovarian syndrome” (PMOS) as a replacement for

July 08, 2026 CHICAGO — Young women referred for polyendocrine metabolic ovarian syndrome (PMOS) had high rates of steatotic liver disease, according to new research.

A study of young women referred for PMOS finds high rates of liver steatosis, while commonly used screening tools miss most cases of liver fibrosis.

November 30, 2020 We and our partners process data to provide: List of Partners (vendors)

Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians with off-label prescribing.

July 13, 2026 Should all adults with diabetes, including those who are asymptomatic, be screened for peripheral vascular disease (PAD)?